Fundraising FoxSynBioVen — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Resurrect Bioresurrect.bioinFeb 2026 · $8.1M
Resurrect Bio develops more durable crop disease resistance by engineering plant immune receptors, combining plant molecular immunology, computational biology, AI, and high-throughput screening.
AgTechAI & Machine LearningBiotechLondon, GB
Cian Duggan(CEO & Co-Founder)inTolga Bozkurt(Co-Founder)inSophien Kamoun(Co-Founder)in
PartnerDavid Harding· solo GP
Co-investorsCalculus Capital Ltd.Future Planet CapitalGrowth Science VenturesPymwymicUK Innovation & Science Seed FundAgFunder
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.